Keyphrases
Clinical Trials
100%
Rofecoxib
100%
Patient Retention
100%
Family Physicians
66%
Placebo
33%
Control Subjects
33%
Colorectal Cancer
33%
Clinical Data
33%
Demographic Data
33%
Predictive Factors
33%
Patient Motivation
33%
Retention Rate
33%
Patient-physician
33%
Colonic Polyps
33%
Randomized Controlled Clinical Trial
33%
Professional Environment
33%
Prospective Randomized Trial
33%
High Retention
33%
Family History of Colorectal Cancer
33%
Analog Scale
33%
Vioxx
33%
Polyp Recurrence
33%
Pharmacology, Toxicology and Pharmaceutical Science
Clinical Trial
100%
Rofecoxib
100%
Colorectal Carcinoma
50%
Placebo
25%
Controlled Clinical Trial
25%
Clinical Study
25%
Recurrent Disease
25%
Colon Polyp
25%
Nursing and Health Professions
Rofecoxib
100%
General Practitioner
50%
Colorectal Carcinoma
50%
Placebo
25%
Family History
25%
Colon Polyp
25%
Recurrent Disease
25%
Biochemistry, Genetics and Molecular Biology
Clinical Trial
100%
Rofecoxib
100%
Clinical Study
25%
Controlled Clinical Trial
25%